「for」の検索結果
117件：51～55件目を表示
-
al Announcement: September 3, 2024 Senju Pharmaceutical Co., Ltd. Acquisition of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuh...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -
Mytear HARD LENS WETTING SOLUTION | OTC Products, etc. | Products | SENJU Pharmaceutical
ARD LENS WETTING SOLUTION Lubricates lenses, allows smooth insertion CHARACTERISTICS Viscous liquid forms a thin layer on the surface of hard or rigid gas permeable lenses. It alleviates the impact of...
http://www.senju.co.jp/english/products/wettingsolution.html -
Publications | Research & Development | SENJU Pharmaceutica
almology. 2026;283:163-175. VIEW PUBLICATION Cost‑effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age‑Related Macular Degeneration and its Subtypes from the Societal and Patient Pers...
http://www.senju.co.jp/english/rd/thesis/ -
Business Activities | About Senju | SENJU Pharmaceutical
ering path in ophthalmic pharmaceuticals. In the hope of developing even more original new products for the future, we have begun to take on the challenge of the five senses. Human innate instincts an...
https://www.senju.co.jp/english/about/business/ -
千寿製薬株式会社
ough TRPV1 Inhibition（PDF） December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Rece...
http://www.senju.co.jp/english/